glp-1 agonist and dpp-4 inhibitor The Role of Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect GLP-1 receptor agonists or DPP-4
Description
(accessed July 18, 2026)
Retatrutide (triple agonist) If tirzepatide was a step forward, retatrutide is a leap
Conversely, the use of liraglutide in the LEADER trial led to a 22% reduction in cardiovascular deaths [53, 54, 56]
These innovations may transform metabolic disease treatment over the next decade
523 Not only hepatocellular carcinoma, but GLP-1 has also shown potential in the treatment of other gastrointestinal tumors
This allows your body to begin the adjustment process while you are resting, giving you a buffer period to see how you feel before heading into a busy work week
